HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antoni Sicras-Mainar Selected Research

Anxiety Disorders (Anxiety Disorder)

2/2019Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin.
1/2015Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain.
1/2014Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antoni Sicras-Mainar Research Topics

Disease

8Pain (Aches)
02/2023 - 12/2012
6Chronic Obstructive Pulmonary Disease (COPD)
11/2022 - 10/2007
6Major Depressive Disorder (Major Depressive Disorders)
12/2021 - 08/2012
6Type 2 Diabetes Mellitus (MODY)
01/2021 - 12/2013
6Neuralgia (Stump Neuralgia)
02/2019 - 12/2012
5Hypoglycemia (Reactive Hypoglycemia)
12/2016 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 10/2007
4Osteoarthritis
01/2022 - 01/2020
3Asthma (Bronchial Asthma)
11/2023 - 01/2022
3Chronic Pain
01/2022 - 01/2020
3Diabetes Mellitus
05/2021 - 10/2007
3Obesity
02/2020 - 02/2008
3Anxiety Disorders (Anxiety Disorder)
02/2019 - 01/2014
3Overactive Urinary Bladder (Overactive Bladder)
12/2015 - 10/2013
3Hypertension (High Blood Pressure)
09/2012 - 03/2008
2Intractable Pain
02/2023 - 03/2021
2Schizophrenia (Dementia Praecox)
01/2023 - 03/2008
2Infections
11/2022 - 01/2022
2Chronic Hepatitis C
11/2022 - 10/2020
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2017 - 03/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2014 - 03/2008
1Heart Diseases (Heart Disease)
03/2024
1Knee Osteoarthritis
02/2023
1Hypercholesterolemia
01/2022
1Impetigo (Impetigo Contagiosa)
01/2022
1Myocardial Infarction
01/2022
1Cognitive Dysfunction
03/2021
1Virus Diseases (Viral Diseases)
10/2020
1Pneumonia (Pneumonitis)
01/2020
1Nociceptive Pain
01/2020
1Thromboembolism
10/2019
1Hemorrhage
10/2019
1Atrial Fibrillation
10/2019
1Stroke (Strokes)
10/2019
1Embolism (Embolus)
10/2019
1Neoplasms (Cancer)
01/2016
1Dementia (Dementias)
03/2014
1Thyroid Diseases (Thyroid Disease)
03/2014
1Anemia
03/2014
1Heart Failure
03/2014
1Skin Ulcer
03/2014
1Parkinson Disease (Parkinson's Disease)
03/2014
1Cardiac Arrhythmias (Arrythmia)
03/2014
1Osteoporosis
03/2014

Drug/Important Bio-Agent (IBA)

6Pregabalin (Lyrica)FDA Link
02/2019 - 12/2012
6Gabapentin (Neurontin)FDA LinkGeneric
01/2018 - 12/2012
5Opioid Analgesics (Opioids)IBA
02/2023 - 01/2020
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2023 - 01/2020
4Muscarinic AntagonistsIBA
01/2022 - 04/2014
4Antidepressive Agents (Antidepressants)IBA
12/2021 - 08/2012
4Metformin (Glucophage)FDA LinkGeneric
11/2014 - 12/2013
3Antipsychotic Agents (Antipsychotics)IBA
01/2023 - 02/2008
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2021
3Hypoglycemic Agents (Hypoglycemics)IBA
02/2020 - 12/2013
3Dipeptidyl-Peptidase IV InhibitorsIBA
02/2015 - 10/2014
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2024 - 10/2007
2Antiviral Agents (Antivirals)IBA
11/2022 - 10/2020
2Analgesics (Analgesic Drugs)IBA
03/2021 - 01/2021
2Insulin (Novolin)FDA Link
01/2021 - 12/2016
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2015 - 11/2014
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2015 - 01/2014
1Ramipril (Altace)FDA LinkGeneric
03/2024
1Atorvastatin (Lipitor)FDA Link
03/2024
13- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
04/2023
1Aripiprazole (Abilify)FDA Link
01/2023
1Central Nervous System AgentsIBA
11/2022
1purpurate-3,3'-diacetic acidIBA
11/2022
1ozenoxacinIBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022
1Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Dipyrone (Metamizole)IBA
01/2022
1Fusidic Acid (Fucithalmic)IBA
01/2022
1LipidsIBA
01/2022
1Mupirocin (Bactroban)FDA LinkGeneric
01/2022
1Serotonin (5 Hydroxytryptamine)IBA
12/2021
1Desvenlafaxine SuccinateFDA Link
12/2021
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2021
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
12/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2021
1Glucagon (Glukagon)FDA Link
05/2021
1Insulin Glargine (Lantus)FDA Link
01/2021
1AcenocoumarolIBA
10/2019
1Vitamin KFDA Link
10/2019
1apixabanIBA
10/2019
1Varenicline (Chantix)FDA Link
01/2017
1Glucagon-Like Peptide-1 ReceptorIBA
12/2016
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2016
1Rituximab (Mabthera)FDA Link
01/2016
1Generic DrugsIBA
01/2015
1Retinaldehyde (Retinal)IBA
03/2014

Therapy/Procedure

13Therapeutics
11/2023 - 03/2008
3Secondary Prevention
03/2024 - 10/2007
3Nebulizers and Vaporizers (Inhaler)
11/2022 - 01/2020
1Aftercare (After-Treatment)
01/2022
1Respiratory Therapy (Therapy, Respiratory)
01/2020
1Activities of Daily Living (ADL)
01/2020
1Injections
12/2016
1Drug Therapy (Chemotherapy)
08/2014